| First Author | Ghazzaui N | Year | 2020 |
| Journal | Blood Adv | Volume | 4 |
| Issue | 1 | Pages | 28-39 |
| PubMed ID | 31899800 | Mgi Jnum | J:307929 |
| Mgi Id | MGI:6726722 | Doi | 10.1182/bloodadvances.2019000845 |
| Citation | Ghazzaui N, et al. (2020) Emu and 3'RR transcriptional enhancers of the IgH locus cooperate to promote c-myc-induced mature B-cell lymphomas. Blood Adv 4(1):28-39 |
| abstractText | Numerous B-cell lymphomas feature translocations linking oncogenes to different locations in the immunoglobulin heavy chain (IgH) locus. During Burkitt lymphoma (BL), IgH breakpoints for c-myc translocation stand either close to JH segments or within switch regions. Transcription, accessibility, and remodeling of the IgH locus are under the control of the 2 potent cis-acting enhancer elements: Emu and the 3' regulatory region (3'RR). To ensure their respective contributions to oncogene deregulation in the context of the endogenous IgH locus, we studied transgenic mice harboring a knock-in of c-myc in various positions of the IgH locus (3' to JH segments, 5' to Cmu with Emu deletion and Calpha). The observed spectrum of tumors, kinetics of emergence, and transcriptome analysis provide strong evidence that both Emu and 3'RR deregulate c-myc and cooperate together to promote B-cell lymphomagenesis. Transgenics mimicking endemic BL (with c-myc placed 3' to JH segments) exhibited the highest rate of B-cell lymphoma emergence, the highest Ki67 index of proliferation, and the highest transcriptomic similarities to human BL. The 3'RR enhancer alone deregulated c-myc and initiated the development of BL-like lymphomas, suggesting that its targeting would be of therapeutic interest to reduce c-myc oncogenicity in vivo. |
